DK1067933T3 - Semisyntetiske ecteinascidiner - Google Patents

Semisyntetiske ecteinascidiner

Info

Publication number
DK1067933T3
DK1067933T3 DK99916379T DK99916379T DK1067933T3 DK 1067933 T3 DK1067933 T3 DK 1067933T3 DK 99916379 T DK99916379 T DK 99916379T DK 99916379 T DK99916379 T DK 99916379T DK 1067933 T3 DK1067933 T3 DK 1067933T3
Authority
DK
Denmark
Prior art keywords
ecteinascidins
semisynthetic
bioactivities
boc
species
Prior art date
Application number
DK99916379T
Other languages
Danish (da)
English (en)
Inventor
Kenneth L Rinehart
Jose J Morales
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Application granted granted Critical
Publication of DK1067933T3 publication Critical patent/DK1067933T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D515/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Dental Preparations (AREA)
  • Hydrogenated Pyridines (AREA)
DK99916379T 1998-04-06 1999-04-05 Semisyntetiske ecteinascidiner DK1067933T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8080298P 1998-04-06 1998-04-06
PCT/US1999/007471 WO1999051238A1 (en) 1998-04-06 1999-04-05 Semi-synthetic ecteinascidins

Publications (1)

Publication Number Publication Date
DK1067933T3 true DK1067933T3 (da) 2007-12-27

Family

ID=22159716

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99916379T DK1067933T3 (da) 1998-04-06 1999-04-05 Semisyntetiske ecteinascidiner

Country Status (27)

Country Link
US (1) US6124293A (cs)
EP (2) EP1876180A3 (cs)
JP (1) JP4443043B2 (cs)
KR (1) KR100603219B1 (cs)
CN (1) CN1157189C (cs)
AT (1) ATE370148T1 (cs)
AU (1) AU758100B2 (cs)
BG (1) BG65088B1 (cs)
BR (1) BR9909488B1 (cs)
CA (1) CA2327468C (cs)
CY (1) CY1106988T1 (cs)
CZ (1) CZ301083B6 (cs)
DE (1) DE69936845T2 (cs)
DK (1) DK1067933T3 (cs)
ES (1) ES2292237T3 (cs)
HU (1) HUP0104273A3 (cs)
IL (2) IL138856A0 (cs)
MX (1) MXPA00009840A (cs)
NO (1) NO328147B1 (cs)
NZ (1) NZ507350A (cs)
PL (1) PL196809B1 (cs)
PT (1) PT1067933E (cs)
RU (1) RU2217432C2 (cs)
SK (1) SK285669B6 (cs)
TR (1) TR200002921T2 (cs)
UA (1) UA59439C2 (cs)
WO (1) WO1999051238A1 (cs)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985876A (en) * 1997-04-15 1999-11-16 Univ Illinois Nucleophile substituted ecteinascidins and N-oxide ecteinascidins
ES2239442T3 (es) * 1998-05-11 2005-09-16 Pharma Mar, S.A. Metabolitos de ecteinascidina 743.
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
AR035842A1 (es) 1999-05-14 2004-07-21 Pharma Mar Sa Metodo de hemisintesis para la formacion de compuestos intermediarios y derivados y de estructuras relacionadas con la ecteinascidina y de tetrahidroisoquinolinfenoles y compuestos intermediarios de aplicacion en dicho metodo
CA2397597A1 (en) 2000-01-19 2001-07-26 The Trustees Of Columbia University In The City Of New York Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
US7919493B2 (en) * 2000-04-12 2011-04-05 Pharma Mar, S.A. Anititumoral ecteinascidin derivatives
MXPA02011319A (es) * 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.
AU2002239565B2 (en) 2000-11-03 2007-11-15 President And Fellows Of Harvard College Saframycins, analogues and uses thereof
IL155781A0 (en) * 2000-11-06 2003-12-23 Pharma Mar Sa Effective antitumor treatments
GB0117402D0 (en) 2001-07-17 2001-09-05 Pharma Mar Sa New antitumoral derivatives of et-743
GB0119243D0 (en) * 2001-08-07 2001-10-03 Pharma Mar Sa Antitumoral analogs of ET-743
GB0202544D0 (en) * 2002-02-04 2002-03-20 Pharma Mar Sa The synthesis of naturally occuring ecteinascidins and related compounds
GB0312407D0 (en) * 2003-05-29 2003-07-02 Pharma Mar Sau Treatment
GB0324201D0 (en) * 2003-10-15 2003-11-19 Pharma Mar Sau Improved antitumoral combinations
US7622458B2 (en) * 2003-11-13 2009-11-24 Pharma Mar, S.A.U. Combination of ET-743 and a 5-fluorouracil pro-drug for cancer treatment
CA2545054A1 (en) * 2003-11-14 2005-06-02 Pharma Mar, S.A. Combination therapy comprising the use of et-743 and paclitaxel for treating cancer
GB0326486D0 (en) * 2003-11-14 2003-12-17 Pharma Mar Sau Combination treatment
JP2008505862A (ja) * 2004-07-09 2008-02-28 ファルマ、マール、ソシエダード、アノニマ 予後分子マーカー
CN101068596A (zh) * 2004-09-29 2007-11-07 法马马私人股份有限公司 艾可特耐思地作抗炎药
KR101287918B1 (ko) * 2004-10-26 2013-07-19 오르토 바이오테크 프로덕츠 엘.피. 엑티나시딘 743과 조합된 페길화된 리포좀 독소루비신
DE602005001833T2 (de) 2004-10-29 2008-04-17 Pharma Mar S.A., Sociedad Unipersonal Zusammensetzungen enthaltend Ecteinascidin und einen Disaccharide
GB0522082D0 (en) * 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
CN100355775C (zh) * 2006-01-20 2007-12-19 南方医科大学 一种海鞘多肽及其制备方法
EP2201141A1 (en) * 2007-10-19 2010-06-30 Pharma Mar S.A. Prognostic molecular markers for et-743 treatment
CA2995033C (en) 2010-11-12 2020-04-28 Pharma Mar, S.A. Combination therapy with an antitumor alkaloid
KR20180103965A (ko) * 2016-02-04 2018-09-19 지앙수 헨그루이 메디슨 컴퍼니 리미티드 위장관 외용을 위한 트라벡테딘-함유 주사가능한 약학적 조성물 및 그의 제조 방법
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
US20230027502A1 (en) 2019-11-21 2023-01-26 Pharma Mar, S.A. Methods of treating small cell lung cancer with lurbinectedin formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256663A (en) * 1986-06-09 1993-10-26 The Board Of Trustees Of The University Of Illinois Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith
US5089273A (en) * 1986-06-09 1992-02-18 Board Of Trustees Of The University Of Illinois Ecteinascidins 729, 743, 745, 759A, 759B and 770
US5149804A (en) * 1990-11-30 1992-09-22 The Board Of Trustees Of The University Of Illinois Ecteinascidins 736 and 722
TW221441B (cs) * 1991-01-25 1994-03-01 Taiho Pharmaceutical Co Ltd
US5440055A (en) * 1993-03-12 1995-08-08 Aphios Corporation Method and apparatus for extracting taxol from source materials
US5478932A (en) * 1993-12-02 1995-12-26 The Board Of Trustees Of The University Of Illinois Ecteinascidins
US5721362A (en) * 1996-09-18 1998-02-24 President And Fellows Of Harvard College Process for producing ecteinascidin compounds

Also Published As

Publication number Publication date
KR20010074474A (ko) 2001-08-04
JP4443043B2 (ja) 2010-03-31
BR9909488A (pt) 2000-12-26
EP1876180A3 (en) 2009-12-16
WO1999051238A9 (en) 2000-01-27
PL196809B1 (pl) 2008-02-29
CA2327468C (en) 2008-05-06
BG65088B1 (bg) 2007-02-28
DE69936845D1 (de) 2007-09-27
IL138856A (en) 2007-07-24
RU2000128058A (ru) 2004-02-20
AU3471399A (en) 1999-10-25
SK15012000A3 (sk) 2001-08-06
SK285669B6 (sk) 2007-06-07
UA59439C2 (uk) 2003-09-15
MXPA00009840A (es) 2002-04-24
CY1106988T1 (el) 2012-09-26
US6124293A (en) 2000-09-26
CA2327468A1 (en) 1999-10-14
WO1999051238A1 (en) 1999-10-14
RU2217432C2 (ru) 2003-11-27
CZ301083B6 (cs) 2009-11-04
NO328147B1 (no) 2009-12-21
EP1067933A1 (en) 2001-01-17
EP1067933B1 (en) 2007-08-15
CN1304309A (zh) 2001-07-18
AU758100B2 (en) 2003-03-13
HUP0104273A2 (hu) 2002-03-28
HUP0104273A3 (en) 2003-12-29
BG104902A (en) 2001-07-31
CN1157189C (zh) 2004-07-14
JP2002510633A (ja) 2002-04-09
EP1876180A2 (en) 2008-01-09
TR200002921T2 (tr) 2001-02-21
ES2292237T3 (es) 2008-03-01
BR9909488B1 (pt) 2011-02-08
PT1067933E (pt) 2007-11-15
KR100603219B1 (ko) 2006-07-20
EP1067933A4 (en) 2002-12-18
IL138856A0 (en) 2001-10-31
DE69936845T2 (de) 2008-05-08
ATE370148T1 (de) 2007-09-15
NZ507350A (en) 2003-03-28
PL343439A1 (en) 2001-08-13
CZ20003650A3 (en) 2001-06-13
NO20004978D0 (no) 2000-10-03
NO20004978L (no) 2000-12-05
HK1033651A1 (en) 2001-09-14

Similar Documents

Publication Publication Date Title
DK1067933T3 (da) Semisyntetiske ecteinascidiner
EA199900936A1 (ru) Фунгицидные трифторметилалкиламинотриазолопиримидины
TR200000065T2 (tr) Epotilon türevleri.
EP0264173A3 (en) Bryostatins
ES2069137T3 (es) Derivados de imidazopiridina y su uso.
NO902394L (no) Fremgangsmaate for fremstilling av pyranyl-cyanoguanidin-derivater.
DE69022368D1 (de) Quinolin-3-carboxanilid-derivate.
DE3683922D1 (de) Chinolinderivate.
DE60013994D1 (de) 1,2-Disubstituierte 1,4-Dihydro-4-oxochinolin-Verbindungen
ES2093037T3 (es) Derivados de beta-lactama y su preparacion.
ATE73768T1 (de) 2,5,6,7-tetranor-18,18,19,19-tetradehydro-4,8inter-m-phenylene-pgi2-derivate.
DE69003050D1 (de) S-substituierte beta-Thioacrylamide und deren Verwendung als Mikrobizide.
EA200200026A1 (ru) ПРОИЗВОДНЫЕ 4'-ДЕМИКАРОЗИЛ-8а-АЗА-8а-ГОМОТИЛОЗИНА
WO2000075158A3 (en) NOVEL 6-PHENYLPURINE 9-β-D-RIBONUCLEOSIDES WITH ANTINEOPLASTIC ACTIVITY, THEIR USE FOR PREPARING PHARMACEUTICAL COMPOSITIONS AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS
SE8700566D0 (sv) Tetracyclic quinazolinones
FR2597105B1 (fr) Derives antibiotiques de la famille des 20-0-acyl-19,20-enolmacrolides
ATE124402T1 (de) 1,4-bis(alkylamino)-2,3-diaza-anthracen-9,10- dione.
NZ314554A (en) Arylthio, -sulphinyl and -sulphonyl pyrrole derivatives, and insecticidal compositions thereof
EP0264951A3 (en) Procaterol-derivatives
SU1351062A1 (ru) Производные шестичленных циклических эфиров, ингибирующие рост золотистого стафилококка